Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation

BACKGROUND: The Israeli National Health Insurance Law was amended in 2010 to require the disclosure of payments above 2500 NIS from pharmaceutical companies (PCs) to medical personnel and organizations. We examined if the law had an impact on the relationship between physicians in the Israeli health...

Descripción completa

Detalles Bibliográficos
Autores principales: Nissanholtz-Gannot, Rachel, Yankellevich, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613310/
https://www.ncbi.nlm.nih.gov/pubmed/28946915
http://dx.doi.org/10.1186/s13584-017-0170-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613310/
https://www.ncbi.nlm.nih.gov/pubmed/28946915
http://dx.doi.org/10.1186/s13584-017-0170-3

Ejemplares similares